Validation of key behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco use by Kim, Hyungjin Myra et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
2012-01-23 
Validation of key behaviourally based mental health diagnoses in 
administrative data: suicide attempt, alcohol abuse, illicit drug 
abuse and tobacco use 
Hyungjin Myra Kim 
University of Michigan 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Psychiatry Commons 
Repository Citation 
Kim HM, Smith EG, Stano CM, Ganoczy D, Zivin K, Walters H, Valenstein M. (2012). Validation of key 
behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit 
drug abuse and tobacco use. Open Access Articles. https://doi.org/10.1186/1472-6963-12-18. Retrieved 
from https://escholarship.umassmed.edu/oapubs/2327 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
RESEARCH ARTICLE Open Access
Validation of key behaviourally based mental
health diagnoses in administrative data: suicide
attempt, alcohol abuse, illicit drug abuse and
tobacco use
Hyungjin Myra Kim1,2*, Eric G Smith3,4, Claire M Stano5, Dara Ganoczy2, Kara Zivin2,5, Heather Walters2,5 and
Marcia Valenstein2,5
Abstract
Background: Observational research frequently uses administrative codes for mental health or substance use
diagnoses and for important behaviours such as suicide attempts. We sought to validate codes (International
Classification of Diseases, 9th edition, clinical modification diagnostic and E-codes) entered in Veterans Health
Administration administrative data for patients with depression versus a gold standard of electronic medical record
text ("chart notation”).
Methods: Three random samples of patients were selected, each stratified by geographic region, gender, and year
of cohort entry, from a VHA depression treatment cohort from April 1, 1999 to September 30, 2004. The first
sample was selected from patients who died by suicide, the second from patients who remained alive on the date
of death of suicide cases, and the third from patients with a new start of a commonly used antidepressant
medication. Four variables were assessed using administrative codes in the year prior to the index date: suicide
attempt, alcohol abuse/dependence, drug abuse/dependence and tobacco use.
Results: Specificity was high (≥ 90%) for all four administrative codes, regardless of the sample. Sensitivity was
≤75% and was particularly low for suicide attempt (≤ 17%). Positive predictive values for alcohol dependence/
abuse and tobacco use were high, but barely better than flipping a coin for illicit drug abuse/dependence.
Sensitivity differed across the three samples, but was highest in the suicide death sample.
Conclusions: Administrative data-based diagnoses among VHA records have high specificity, but low sensitivity.
The accuracy level varies by different diagnosis and by different patient subgroup.
Background
In many administrative data-based studies, most vari-
ables, including primary outcomes, are based on the
International Classification of Diseases (ICD), clinical
modification codes (ICD-9 or ICD-10). Although the cri-
teria for these diagnoses codes are clearly delineated, the
primary purpose of these codes in many health systems
is for billing. However, these codes are often used in
health services research.
Administrative codes may have issues with sensitivity,
specificity or accuracy when used for research purposes.
Some level of financial incentive exists for the clinicians
and billing clerks to note all relevant diagnoses (e.g.,
slightly higher billing revenues for the clinician or the
system). However, even if each diagnosis or condition of
interest covered in an encounter is faithfully entered,
other diagnoses that were not a clinical focus in a parti-
cular encounter will not be entered. In addition, a desire
to avoid stigma may play a role in the under-coding of
behavioural health issues, such as substance dependence
or suicide attempts. As a further complication, the diag-
nostic criteria for some of these behaviourally-based
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conditions are more subjective than for medical condi-
tions, which may interplay with desire to avoid stigma
in using certain diagnostic codes. For instance, depen-
dence criteria require clinicians to make a judgment
about whether behaviours “substantially impair” the
patient. Similarly, suicide attempt diagnoses often call
for a judgment of whether the patient intended to harm
oneself. Lastly, some codes, such as the E-codes used for
suicide attempts, generate no financial reimbursement,
and the only incentive for the clinician to enter this
information is typically to better inform future care of
the patient.
As a result, it has long been recognized that adminis-
trative codes sub-optimally represent a patient’s condi-
tion and the totality of all their comorbid illnesses,
especially for conditions relating to mental illness [1].
Validation of such coding with individual chart review is
desirable [2] because large health care organizations
such as the Veterans Affairs (VA) Health Systems,
Veterans Health Administration (VHA), use these
administrative data for quality improvement purposes,
to assess patient outcomes, and to determine health ser-
vices utilization [3,4]. With increasing numbers of out-
comes and health services research studies based
exclusively or primarily on administrative data, knowl-
edge of the accuracy of various potential research vari-
ables typically obtained from administrative data is
highly desirable, as the validity of any conclusions will
depend largely on the validity of such data.
VHA and non-VHA researchers have compared medi-
cal charts and administrative records, and studies have
reported that the quality of VHA data is steadily
improving [3]. Szeto et al. found the sensitivities and
specificities for several medical diagnoses in the VHA
administrative data to be high with sensitivity greater
than 80% for 8 of 9 diagnoses that are relevant to the
choices of hypertension medication and higher than 91%
specificity for all 9 diagnoses [5]. Studies that have vali-
dated administrative data for mental health services
research have focused on diagnoses such as schizophre-
nia or depression [6,7], a range of mental health service
provision by primary care physicians [8,9], or perfor-
mance measures [10-12]. A study by Kashner et al.
comparing medical charts and administrative records of
inpatient VHA discharges in 1995 found 93.7% agree-
ment for alcohol dependence syndrome and 95.2% for
drug dependence [13]. More recently, a Canadian study
reported low sensitivity and high specificity for alcohol
abuse and for drug abuse by comparing ICD-9 based
diagnoses against the chart diagnoses in patients
admitted in 2003 at four teaching hospitals in Alberta
[14]. However, no study, to our knowledge has validated
behavioural mental health variables in patients with
depression.
VHA patients are different from the general popula-
tion in that they have higher rates of mental illness and
substance abuse, and patients with depression have
higher rates of co-morbid substance abuse compared to
those without mental illness. This study examines dis-
crepancies between administrative data and chart notes
with regard to behaviourally based mental health diag-
noses in a VHA population with depression. Specifically,
we sought to assess the validity of diagnoses based on
ICD codes and E-codes for four variables frequently
used in administrative data-based mental health studies:
suicide attempt, alcohol abuse or dependence, drug
abuse or dependence, and tobacco use disorder. The
validation was carried out by comparing diagnostic cod-
ing and individual chart review data, using the Veterans
Health Administration’s comprehensive [electronic med-
ical record] computerized patient record system.
Though chart notation is not expected to be fully com-
prehensive or without errors, we expected it to be more
comprehensive than the diagnostic coding.
Given the complexity of factors likely to influence
administrative coding of these conditions, we did not
hypothesize which of the administrative codes may have
the highest levels of sensitivity or specificity for data
recorded in charts. However, given low numbers of
administrative codes for suicide attempt, we hypothe-
sized that suicide attempt codes may have low sensitivity
for attempts noted in the medical chart notations.
Methods
This retroactive chart abstraction study was conducted
as a nested case control study as part of a larger phar-
macoepidemiologic study to compare suicide risks
across different antidepressants. The study included
three random samples made of 368 patients who died
by suicide, 362 control patients, and 571 new users of
antidepressants. The samples were selected from the
cohort of Veterans Health Administration (VHA)
patients identified using administrative data as being in
VHA depression treatment, with either two diagnoses of
a depressive disorder or a depression diagnosis and an
antidepressant start between 4/1/1999 and 9/30/2004
[4]. The study was conducted with institutional review
board approval from the Veterans Affairs Health System.
The suicide death sample was randomly selected from
individuals who died of suicide, stratified by year of
entry into the depression cohort, four geographic
regions of the patient’s VHA facility of most use and
gender. Suicide deaths were determined using data from
the National Death Index (NDI), which is considered
the “gold standard” in US mortality databases [15]. The
sampling fraction was proportional to that of the total
suicide population, except females were over-sampled
(15% females to 85% males) within each stratum due to
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small number of females in the VHA who completed
suicides. The control sample was obtained by selecting a
random patient to match each patient in the suicide
death sample on age (+/- 5 years) from those in the
same stratum as the case patient and alive on the date
of suicide (i.e., index date). This last step was done in
order to assign an index date to determine diagnoses for
control sample patients. The antidepressant new user
sample was selected from the depression cohort, from
the subgroup of those newly starting one of the seven
most commonly used antidepressants: bupropion, citalo-
pram, fluoxetine, mirtazapine, paroxetine, sertraline and
venlafaxine. A new start of an antidepressant was
defined as a start of an antidepressant after no antide-
pressant fills for at least 6 months. These seven antide-
pressants make up more than 90% of all new
antidepressant fills. Again a random sample was
selected, stratified by region, year of new start and the
seven antidepressant agents with approximately equal
number of patients across strata (i.e., disproportionate
sampling was used).
Index Date
The index date was defined as date of suicide death for
patients in the suicide death sample and also for
patients in the control sample (who were alive on that
date). For the new antidepressant user group, the index
date was the date of the new antidepressant start. Beha-
vioural variables of interest were assessed using all
administrative and chart note data for the year prior to
and including the index dates. We chose to assess beha-
vioural variables during the entire one year period
because in research studies comorbid health conditions
are not typically determined from a single encounter
but based on all encounters from a longer period [4].
Administrative Data Diagnoses
Administrative data variables were based on diagnoses
recorded in any diagnosis field of inpatient stays and
outpatient visits. Diagnoses were based on the Interna-
tional Classification of Diseases, Ninth Revision, clinical
modification (ICD-9) diagnoses codes. Alcohol and drug
indicators included diagnoses of current alcohol or drug
abuse and/or dependence. If the ICD-9 diagnoses code
indicated the alcohol or drug disorder was in remission,
abuse or dependence was considered not present at that
visit. However, if a diagnosis of substance dependence/
abuse was recorded at any encounter during the year,
the patient was identified as having a substance depen-
dence/abuse disorder, even if a remission code was
recorded later in the year. Additional file 1 shows the
included and excluded diagnoses for each of the four
key behavioural variables. Drug dependence/abuse diag-
noses included cocaine, opioids, cannabis, barbiturates,
amphetamines, hallucinogens and other specified or
unspecified drugs.
Chart Abstracted Diagnoses
Charts were abstracted by four trained reviewers. Man-
ual chart reviews were completed with the aid of a pre-
viously validated electronic medical record search
engine (EMERSE), which highlights words in pre-defined
search bundles [16]. Search bundles were developed,
pilot-tested and refined for each variable and made to
contain terms that would broadly capture all notations
related to the specific conditions (i.e., “suicidal ideation”
or “hurt” for the suicidal attempt variable.) Four chart
reviewers underwent training with pilot data to resolve
discrepancies and to improve accuracy and agreement
in abstraction. However, for abstractions included in
this study, 92% of study patients were reviewed by one
reviewer with the aid of EMERSE. The reviewers were
blinded to administrative data and the sample to which
each patient belonged.
For suicide attempt, any notation regarding an attempt
at any time during one year prior to the index date such
as “Client was brought to ER after wife found him with
wrists slashed” was considered as presence of suicide
attempt. For alcohol use, problem use, abuse or depen-
dence was considered present if, for example, the num-
ber of drinks per session was noted to be on or above
the binge drinking threshold (4 drinks per session for
women and 5 drinks per session for men), the clinician
instructed patients to stop or reduce their drinking, or
referred them to a substance use treatment program.
Alcohol problem use/abuse/dependence was not consid-
ered present in chart notes if alcohol use was not men-
tioned, no use was reported or use was reported without
problem. For other drug use, illicit drug problem use/
abuse/dependence included any illicit substance use,
other than marijuana. For patients who reported mari-
juana use only, problem use included those who
reported problem behaviours or were instructed to stop
use by their clinician. Tobacco use was considered pre-
sent if any notation of current smoking by the patient
was recorded during the year prior to the index date,
either as part of the mandatory VHA yearly tobacco
screening or elsewhere in the record.
Data Analysis
Within each patient sample, percent agreement and
kappa values were calculated to assess agreement in the
four behavioural variables determined by administrative
data versus chart abstraction. All measures of accuracy,
including sensitivity, specificity, positive predictive value
(PPV) and negative predictive value (NPV), were calcu-
lated using chart notation as the “gold standard.” In
addition to accuracy measures for each sample, we also
Kim et al. BMC Health Services Research 2012, 12:18
http://www.biomedcentral.com/1472-6963/12/18
Page 3 of 9
calculated unbiased estimates of various accuracy mea-
sures for the entire depression cohort during the study
period from 4/1/1999 to 9/30/2004. This was done
using the combined mutually exclusive samples of sui-
cide deaths and controls where the estimates were
adjusted for sampling weights with each observation
weighted inversely by the number of people each repre-
sents in the full depression cohort based on the sam-
pling strata. Weighted accuracy estimates based on the
antidepressant user sample were also calculated as
unbiased accuracy estimates of a cohort of patients
newly starting an antidepressant during the study per-
iod. We also did the analyses by age groups for alcohol
problem drinking/abuse/dependence, our most common
set of diagnoses. All analyses were done using Stata 10.1
(StataCorp LP, College Station, TX).
Results
Table 1 shows demographic clinical utilization charac-
teristics during the one year prior to the index date by
the different samples. Overall, the samples were 76%
white, 88% male and 4% Hispanic. On average, 85% of
patients had more than one visit in the 12 months prior
to the index date from which to abstract data, with a
slightly lower percentage having more than one visit in
the antidepressant new user sample.
Suicide Attempt
Table 2 shows the various measures by the different
samples. Percent agreement for suicide attempt was low-
est (87.8%) in the sample of patients who eventually
died by suicide, but higher in the control sample
(99.2%) and in the new user sample (97.0%). Sensitivity
of administrative codes for suicide attempt was low
across all samples, with highest sensitivity of 17.0% in
the suicide death sample. Specificity was 100% for both
the control sample and the antidepressant new user
sample and was 99.7% for the suicide death sample. In
the suicide death sample, one patient had an attempt
coded in administrative data on the date of completed
suicide, but without a chart notation. Sampling fraction-
adjusted (weighted) sensitivity for suicide attempt was
2.1% and the specificity 99.9% for the depression cohort,
i.e., the combined suicide death and control samples.
Alcohol Problem Drinking/Abuse/Dependence
Table 3 shows the administrative data vs. chart compari-
sons for alcohol, drug, and tobacco use diagnoses.
Administrative codes for alcohol abuse or dependence
had specificity greater than 96% in all three samples.
Sensitivity, however, was lower than 74% in all three
samples (weighted sensitivity estimates were lower than
78%), with the lowest sensitivity (53.8%) in the control
sample. In the combined sample of cases and controls,
sensitivity was 68.2%, specificity was 96.9%, positive pre-
dictive value of alcohol abuse diagnosis in administrative
data was 87.4%, and negative predictive value was 90.8%.
Illicit Drug Problem Use/Abuse/Dependence
Specificity of administrative codes for chart notation of
illicit drug use was higher than 90% across all samples
(Table 3). Sensitivity, however, was much lower. The
highest sensitivity (74.3%) was observed in the suicide
death sample, and the lowest sensitivity (57.9%) was
observed in the control sample. Positive predictive value
of illicit drug use diagnosis in the administrative data
was very low across the three samples, with the estimate
in the combined suicide death and control samples of
only 52.1% (weighted estimate was 69.5%).
Tobacco Use
For tobacco use, the various accuracy measures varied
least among the three different samples, and the
unweighted and weighted estimates were similar. In the
combined suicide death and control sample, sampling
fraction-adjusted sensitivity was 38.6%, specificity 97.8%,
positive predictive value of tobacco use diagnosis 91.2%
and negative predictive value of tobacco use diagnosis
73.2%.
By Age Group
For alcohol abuse/dependence, specificity remained very
similar across the samples and between age groups (<
50 vs. ≥ 50 years old). On the other hand, sensitivity
was higher in < 50 year olds than in ≥ 50 year olds in
both the suicide and control samples. In the suicide
sample, unweighted sensitivity was 85.2% (95% CI =
73.8-93.0%) in younger patients, and 63.3% (49.9-75.4%)
in older patients, and similarly, in the control sample,
sensitivity was 60.0% (38.7-78.9%) in younger patients
and 48.1% (28.7-68.1%) in older patients. Prevalence of
alcohol abuse/dependence based on chart data was
Table 1 Patient characteristics by the three different
samples
Suicide Deaths Controls AD New Users
(N = 368) (N = 362) (N = 571)
Characteristics N (%) N (%) N (%)
Male 312 (84.8) 311 (85.9) 520 (91.1)
Hispanic 8 (2.2) 17 (4.7) 26 (4.6)
White 290 (78.8) 274 (75.7) 431 (75.5)
Age (mean (SD)) 57.5 (14.3) 57.6 (14.5) 56.2 (14.2)
0 Outpatient Visita 31 (8.4) 34 (9.4) 15 (2.6)
1 Outpatient Visita 19 (5.2) 12 (3.3) 80 (14.0)
> 1 Outpatient Visita 318 (86.4) 316 (87.3) 476 (83.4)
Abbreviation: AD is antidepressants.
a During the year of assessment considered for this study.
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about 2.2 times (p < 0.001) higher in the suicide than
the control sample, and 1.8 times (p < 0.001) higher in
the younger than the older subgroup within each sam-
ple. Total number of mental health visits over the prior
12 months of the index visits was also higher in the case
sample than control sample, and higher in the younger
than the older subgroup within each sample; mean
number of mental health outpatient visits were 8.7, 4.6,
4.3 and 3.3 for younger subgroup in the suicide sample,
older subgroup in the suicide sample, younger subgroup
in the control sample, and older subgroup in the control
sample, respectively.
Estimated Prevalence across Data Sources
As an illustration of the potential impact of misclassifi-
cation and differential misclassification, we calculated
sampling fraction-adjusted prevalence of each condition
based on chart data as well as administrative data (Table
4). In the combined suicide death and control sample,
the prevalence of suicide attempt was 0.4% using chart
data, while it was only 0.008% using administrative data.
The prevalence of alcohol problem drinking/abuse/
dependence was 17.6% vs. 12.0%, and of illicit drug pro-
blem use/abuse/dependence was 5.3% vs. 4.6%, using
chart data vs. administrative data, respectively. Tobacco
use diagnosis showed a bigger discrepancy than alcohol
or drug dependence diagnoses where the prevalence was
36.8% using chart data, but only 15.6% using administra-
tive data.
Discussion
Studies using administrative data rely on the accuracy of
the ICD-9 diagnostic codes. This study was conducted
to validate the administrative diagnoses of four key
behavioural variables often used in mental health and
health services research by comparing them to the pre-
sence of the corresponding conditions in chart notation.
Overall agreement and specificity were generally high
across all behavioural variables. Sensitivity, however, was
substantially lower than optimal (< 75%) for all four
variables, and was particularly low for suicide attempt.
Sensitivity was consistently highest in the suicide sam-
ple, followed by the antidepressant new user sample and
lowest in the controls sample, likely due to more visits,
service use and chart data for patients with greater
severity or changes in severity. We note that due to the
low prevalence of suicide attempts, the sensitivity esti-
mates of suicide attempt are generally not as precise (e.
g., one-sided 95% upper confidence limit for sensitivity
of the control sample is 63%). Negative predictive values
of administrative codes for behavioural variables were
generally high, although positive predictive values varied.
Positive predictive values of administrative codes for
alcohol problems were 72-94%, and for tobacco use
were 89-95%. However, for illicit drug use, PPV was
only 48-65%.
Kashner et al. compared medical charts and adminis-
trative records for a random sample of 414 VHA inpati-
ent discharges between July 1 and September 30, 1995
and found 93.7% agreement for alcohol dependence syn-
drome and 95.2% for drug dependence [13]. Our find-
ings of 90.1% agreement for alcohol dependence and
96.1% agreement for drug dependence are similar to
these findings. Their study did not report sensitivity and
specificity; however, based on data presented in the
paper, for alcohol dependence, their sensitivity and
Table 2 Suicide attempt: comparison of administrative data using E-codes against suicide attempt notation in chartc,
both during the past 12 months prior to and including the index date
Unweighted Estimates, %b (N in fraction)
Samples Agreement Sensitivity Specificity PPV NPV
Suicide Death 88 (323/368) 17 (9/53) 100 (314/315) 90 (9/10) 88 (314/358)
Control 99 (359/362) 0 (0/3) 100 (359/359) NA1 99 (359/362)
AD New User 97 (554/571) 11 (2/19) 100 (552/552) 100 (2/2) 97 (552/569)
Combineda 93 (682/730) 16 (9/56) 100 (673/674) 90 (9/10) 94 (673/720)
Weighted Estimates, %b (95% confidence interval)
Suicide Death 87 (82, 92) 19 (5, 32) 100 (100, 100) 96 (85, 100) 87 (82, 91)
Control 100 (99, 100) 0 100 NA1 100 (99, 1.00)
AD New User 98 (95, 100) 25 (0, 72) 100 NA2 98 (95, 100)
Combineda 100 (99, 100) 2 (0, 5) 100 (100, 100) NA1 100 (99, 100)
Abbreviation: NA1 is not appropriate (inappropriate to estimate because the N of the denominator is 0 for the unweighted estimate and thus the corresponding
weighted estimates based partly or entirely on the control sample are also inappropriate); NA2 is not appropriate (inappropriate because weighting would be
based on N = 2); AD is antidepressant; PPV is positive predictive value of an administrative diagnosis; NPV is the negative predictive value of an administrative
diagnosis.
a Combined sample of suicide deaths and controls
b Rounded to a whole number
c The chart notation had to be clear it was referring to a suicide attempt occurring in the past 12 months.
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specificity were 69.4% and 95.5%, respectively. For illicit
drug dependence, sensitivity and specificity were 72.1%
and 96.6%, respectively. These findings of high specifi-
city are similar to our results, but sensitivity is higher
than that found in our study. This higher sensitivity in
Kashner et al. may be due to basing the study on
inpatient discharges rather than the more comprehen-
sive data available from chart review. A more recent
Canadian study based on 4,008 randomly selected
patients admitted from January 1 to June 30, 2003 at
four teaching hospitals in Alberta reported 53.6% sensi-
tivity and 99.1% specificity for alcohol abuse and 55.3%
Table 3 Alcohol dependence, illicit drug dependence and tobacco use diagnoses: comparison of administrative
diagnoses against chart notation during the past 12 months prior to and including the index date
Alcohol Problems, Abuse/Dependence
Unweighted Estimates, %b (N in fraction)
Sample Agreement Sensitivity Specificity PPV NPV
Suicide Death 90 (331/368) 74 (90/121) 98 (241/247) 94 (90/96) 89 (241/272)
Control 90 (327/362) 54 (28/52) 96 (299/310) 72 (28/39) 93 (299/323)
AD New User 90 (515/571) 63 (73/116) 97 (442/455) 85 (73/86) 91 (442/485)
Combineda 90 (658/730) 68 (118/173) 97 (540/557) 87 (118/135) 91 (540/595)
Weighted Estimates, %b (95% confidence interval)
Suicide Death 90 (87, 94) 78 (70, 87) 97 (95, 100) 94 (88, 100) 89 (84, 93)
Control 90 (85, 95) 55 (34, 75) 97 (95, 99) 80 (67, 94) 91 (86, 96)
AD New User 91 (87, 94) 59 (46, 73) 98 (96, 100) 86 (75, 97) 91 (88, 95)
Combineda 90 (85, 95) 55 (35, 75) 97 (95, 99) 80 (68, 93) 91 (86, 96)
Illicit Drug Use/Abuse/Dependence
Unweighted Estimates, %b (N in fraction)
Agreement Sensitivity Specificity PPV NPV
Suicide Death 90 (331/368) 74 (26/35) 92 (305/333) 48 (26/54) 97 (305/314)
Control 96 (348/362) 58 (11/19) 98 (337/343) 65 (11/17) 98 (337/345)
AD New User 93 (533/571) 70 (38/54) 96 (495/517) 63 (38/60) 97 (495/511)
Combineda 93 (679/730) 69 (37/54) 95 (642/676) 52 (37/71) 97 (642/659)
Weighted Estimates, %b (95% confidence interval)
Suicide Death 90 (86, 94) 78 (62, 94) 92 (88, 95) 51 (35, 67) 97 (95 99)
Control 97 (94, 99) 61 (30, 91) 99 (97, 100) 70 (43, 96) 98 (96, 100)
AD New User 91 (85, 96) 54 (24, 85) 95 (92, 98) 58 (37, 79) 94 (89, 100)
Combineda 97 (94, 99) 61 (33, 89) 99 (97, 100) 69 (45, 93) 98 (96, 100)
Tobacco Use
Unweighted Estimates, %b (N in fraction)
Agreement Sensitivity Specificity PPV NPV
Suicide Death 73 (267/368) 42 (70/167) 98 (197/201) 95 (70/74) 67 (197/294)
Control 76 (274/362) 36 (46/128) 97 (228/234) 89 (46/52) 74 (228/310)
AD New User 74 (424/571) 40 (95/237) 99 (329/334) 95 (95/100) 70 (329/471)
Combineda 74 (541/730) 39 (116/295) 98 (425/435) 92 (116/126) 70 (425/604)
Weighted Estimates, %b (95% confidence interval)
Suicide Death 70 (64, 76) 42 (33, 52) 97 (94, 100) 94 (87, 100) 63 (56, 70)
Control 76 (70, 82) 39 (27, 50) 98 (96, 100) 91 (83, 99) 73 (66, 80)
AD New User 77 (72, 82) 44 (34, 54) 99 (97, 100) 95 (90, 100) 73 (67, 79)
Combineda 76 (70, 82) 39 (27, 50) 98 (96, 100) 91 (84, 99) 73 (66, 80)
Note: For alcohol dependence, kappa values are 0.76 for suicide cases, 0.57 for controls and 0.66 for AD new users. For illicit drug dependence, kappa values are
0.53 for suicide cases, 0.55 for controls and 0.63 for AD new users.
Abbreviation: NA is not available, AD is antidepressant; PPV is positive predictive value of an administrative diagnosis; NPV is the negative predictive value of an
administrative diagnosis.
a Combined sample of suicide deaths and controls
b Rounded to a whole number
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sensitivity and 99.0% specificity for drug abuse by com-
paring ICD-9 based diagnoses against the chart diag-
noses [14]. This finding is similar to ours, except we
have slightly lower specificities (weighted accuracy of
97.2% for alcohol abuse and 98.5% for drug abuse).
The lower-than-desirable coding of these variables,
and in particular of suicide attempt, might be antici-
pated. However, numerous studies have used these vari-
ables as covariates or even as primary endpoints [17].
Unfortunately, if misclassification is such that a large
proportion of these behavioural variables (e.g., suicide
attempts) are missed, it will lead to an under-estimation
not only of the prevalence of the particular condition,
but also may have an impact on effect size estimates of
interest. In addition, when accuracy of classification is
different across the different subgroups, the systematic
bias often can mask an association or create a spurious
one, depending on the study design. For example, if sui-
cide attempt is more accurately identified in drug users
than non-drug users, the differential accuracy of suicide
attempt may potentially lead to a spurious association
between drug use and suicide attempt. Increasing the
sample size will not eliminate such biases.
Assuming that chart diagnosis is the gold standard,
the generally high specificity means that over-estimation
of the prevalence based on administrative data from
false positives is not likely. On the other hand, the low
sensitivity indicates that administrative data-based diag-
noses are likely to under-estimate the prevalence, and
this has been seen across all four behavioural diagnoses.
Although neither low sensitivity nor low specificity are
desirable, the impact of drawing conclusions based on
variables with low sensitivity combined with high speci-
ficity is likely less undesirable than the conclusions
drawn from studies based on variables with low specifi-
city and high sensitivity. In studies where variables with
low specificity are used, false positives will likely bias
the estimation of the effects of interest whether the vari-
ables are used as endpoints or as primary predictors.
However, in studies where variables with low sensitivity
are used as primary endpoints, mainly statistical power
will be reduced due to under-identified events. Similarly,
in studies where these variables are used as predictors
or covariates, the predictive power will be compromised
and thus any adjustments for selection bias, for example,
will not be as effective.
There are limitations to this study. Our study used
data from the 12 months prior to index date, and a
greater number of visits or longer length of any inpati-
ent stays within the 12 months are likely to give a
greater amount of information in both charts and
administrative databases. Thus our results do not neces-
sarily generalize to level of agreement for a single visit
or a single inpatient stay. Our results may not be fully
generalizable to patients without a depression diagnosis
or care delivered outside of the VHA or to care deliv-
ered during other time periods within the VA. We also
note that the time period of this study precedes multiple
clinical initiatives the VHA has taken to increase the
detection of suicidal behaviour and reduce suicide risk.
Clinical reminders requiring screening for tobacco use
[18] is in the developmental stage in the VHA, and
started nationally in 2008 for alcohol abuse/dependence
(based on the AUDIT questionnaire) [19]. The VHA
system potentially has fewer financial incentives to pro-
mote full diagnostic coding than many private sector
settings, although the VHA allows up to 10 diagnostic
fields for each encounter and has an electronic medical
record that makes recording of conditions simple for
busy clinicians, potentially enhancing the completeness
of coding at each visit.
Another limitation is the lack of a true gold standard
for these conditions. Both the chart notations and
administrative diagnostic codes are limited to events
that come to attention of VHA providers; thus medical
records are a gold standard only in terms of recognized
and diagnosed disorders that a clinician recorded. For
substance use disorders, actual prevalence would, likely
be much higher if validated diagnostic instruments were
used. Many persons with such disorders are not identi-
fied and not treated. For instance, if a patient presents
to an outside ER after a suicide attempt, this would not
be captured within the VHA record unless they subse-
quently reported such an event to a medical or mental
health provider. The goal of the study, however, is not
to validate the administrative ICD-9 codes for suicide
attempts and three substance use diagnoses using the
true diagnosis, but to validate them using chart notation
Table 4 Weighted prevalence estimates based on chart and on administrative (ICD-9) data
Suicide Attempt Alcohol
Abuse
Illicit Drug Abuse Tobacco
Use
Sample Chart ICD-9 Chart ICD-9 Chart ICD-9 Chart ICD-9
Suicide Death 15.9 3.1 35.7 29.7 10.2 15.6 49.5 22.4
Control 0.3 0 17.5 11.9 5.3 4.6 36.8 15.5
AD New User 3.1 0.8 18.5 12.8 11.1 10.5 39.2 18.2
Suicides & Controls 0.4 0.008 17.6 12.0 5.3 4.6 36.8 15.6
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data which would be a more accurate, but more expen-
sive source – though less expensive than surveys – of
the behavioural disorder diagnoses in typical health ser-
vices research studies.
Despite the limitations, the strength of our study is
that it is based on samples drawn from complete nation-
wide records for all VHA patients, where all billing for
patient care, even for specialists, occurs through the
computer. We also note that our sampling was done to
represent patients across region, years and gender and
thus represent carefully the depression cohort at the
VHA across regions over 5 years. Most importantly, to
our knowledge this is the first study where agreement in
suicide attempts determined by chart notation and E-
codes was evaluated.
Conclusions
Administrative data-based diagnoses among VHA
records have high specificity but low sensitivity. How-
ever, the accuracy level varies by diagnosis and by
patient subgroup. Given the lower than desirable level
of accuracy, particularly of sensitivity, studies using
behavioural diagnosis variables evaluated in this study as
the primary endpoint or predictor should be careful in
assessing the implication of potential misclassifications
on their findings.
Additional material
Additional File 1: International Classification of Diseases, Ninth
Revision, clinical modification (ICD-9-CM) diagnoses codes used for
determining presence of the administrative data based diagnoses.
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